Novartis (NVS) said to weight selling ritalin, clozaril, exelon drugs - Bloomberg

November 22, 2016 6:58 AM EST

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Novartis (NYSE: NVS) said to weight selling ritalin, clozaril, exelon drugs, according to Bloomberg headlines. The drugs could bring in over $300 million for the company.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Mergers and Acquisitions, Rumors, Spinoffs, Trader Talk

Add Your Comment